CLAUDIA ROMO: Open Payments
NPI 1487196002 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 78 payments from 18 companies in 2025. Trend: 2023 $1,564 · 2024 $1,399 · 2025 $1,499
Food & beverage: $1,499
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $375 |
| AstraZeneca Pharmaceuticals LP | 14 | $301 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $168 |
| Saluda Medical Americas, Inc. | 3 | $112 |
| Novo Nordisk Inc | 5 | $101 |
| Abbott Laboratories | 3 | $83 |
| Lilly USA, LLC | 4 | $67 |
| Dexcom, Inc. | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
Products named: QULIPTA, Kerendia, FARXIGA, AIRSUPRA, Evoke, UBRELVY, FREESTYLE LIBRE 3, Ozempic.
Industry payments across AZ — which companies pay providers there.
